About this trial
Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann.
Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s, radiological outcomes, and anticipated or procedure-related adverse events (i.e. complications).
Eligibility criteria
Qualifiers
Age 65 years or older at time of injury
Diagnosis, via CT scan as per standard of care, of FFP grade II or higher according to the Rommens and Hofmann classification (including fractures of the anterior pelvic ring involving the anterior lip of the acetabulum not regarded as the acetabular fractures)
Ability to understand the content of the patient information/ICF
Willingness and ability to participate in the registry according to the standard of care in each clinic
Disqualifiers
Pelvic fractures that do not meet the criteria of a fragility fracture (ie, high-energy trauma)
FFP type I fractures
Concomitant fractures of the acetabulum (except anterior lip of the acetabulum, see above)
Pathological fractures (ie, patients with malignant or metastatic diseases of the pelvis, infections)
Trial design
Treatments tested in this trial
- Not listed